Border-associated macrophages mediate the neuroinflammatory response in an alpha-synuclein model of Parkinson disease

被引:48
|
作者
Schonhoff, A. M. [1 ,2 ]
Figge, D. A. [3 ]
Williams, G. P. [1 ,2 ]
Jurkuvenaite, A. [1 ,2 ]
Gallups, N. J. [2 ]
Childers, G. M. [2 ]
Webster, J. M. [1 ,2 ]
Standaert, D. G. [1 ,2 ]
Goldman, J. E. [1 ,4 ]
Harms, A. S. [1 ,2 ]
机构
[1] Aligning Sci Parkinsons ASAP Collaborat Res Networ, Chevy Chase, MD 20815 USA
[2] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Dept Neurol, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Dept Pathol, Sch Med, Birmingham, AL USA
[4] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA
关键词
MOUSE MODEL; MICROGLIAL ACTIVATION; T-CELLS; BRAIN; NEURODEGENERATION; INFILTRATION; INFLAMMATION; EXPRESSION; FATE;
D O I
10.1038/s41467-023-39060-w
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Dopaminergic cell loss due to the accumulation of & alpha;-syn is a core feature of the pathogenesis of Parkinson disease. Neuroinflammation specifically induced by & alpha;-synuclein has been shown to exacerbate neurodegeneration, yet the role of central nervous system (CNS) resident macrophages in this process remains unclear. We found that a specific subset of CNS resident macrophages, border-associated macrophages (BAMs), play an essential role in mediating & alpha;-synuclein related neuroinflammation due to their unique role as the antigen presenting cells necessary to initiate a CD4 T cell response whereas the loss of MHCII antigen presentation on microglia had no effect on neuroinflammation. Furthermore, & alpha;-synuclein expression led to an expansion in border-associated macrophage numbers and a unique damage-associated activation state. Through a combinatorial approach of single-cell RNA sequencing and depletion experiments, we found that border-associated macrophages played an essential role in immune cell recruitment, infiltration, and antigen presentation. Furthermore, border-associated macrophages were identified in post-mortem PD brain in close proximity to T cells. These results point to a role for border-associated macrophages in mediating the pathogenesis of Parkinson disease through their role in the orchestration of the & alpha;-synuclein-mediated neuroinflammatory response. Neuroinflammatory mechanisms are implicated in Parkinson disease. Here we identify border-associated macrophages (BAMs), as essential for the & alpha;-synuclein-mediated neuroinflammatory response via class II antigen presentation, and T cell infiltration.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Familial Parkinson's disease - The awakening of alpha-synuclein
    Goedert, M
    NATURE, 1997, 388 (6639) : 232 - 233
  • [42] Sumoylation of alpha-synuclein in the pathogenesis of parkinson's disease
    Engelender, S.
    JOURNAL OF NEUROCHEMISTRY, 2019, 150 : 48 - 48
  • [43] Autoantibodies to alpha-synuclein in inherited Parkinson's disease
    Papachroni, Katerina K.
    Ninkina, Natalia
    Papapanagiotou, Angeliki
    Hadjigeorgiou, Georgios M.
    Xiromerisiou, Georgia
    Papadimitriou, Alexandros
    Kalofoutis, Anastasios
    Buchman, Vladimir L.
    JOURNAL OF NEUROCHEMISTRY, 2007, 101 (03) : 749 - 756
  • [44] A Characterization of Misfolded Alpha-Synuclein in Parkinson's Disease
    Shannon, Daniel
    Bugada, John-Paul
    Collins, Ethan
    Fischer, Ellie
    Hellard, Delaney
    Hoffman, Trevor
    Kellogg, Nick
    Peters, Kyle
    Poetker, Garret
    Young, Logan
    Diao, JiaJie
    FASEB JOURNAL, 2020, 34
  • [45] Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease
    Dolgacheva L.P.
    Fedotova E.I.
    Abramov A.Y.
    Berezhnov A.V.
    Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology, 2018, 12 (1) : 10 - 19
  • [46] Alpha-synuclein and presynaptic functionImplications for Parkinson’s disease
    Simon Lykkebo
    Poul Henning Jensen
    NeuroMolecular Medicine, 2002, 2 : 115 - 129
  • [47] Role of alpha-synuclein and tau in Parkinson's disease
    Trojanowski, JQ
    MOVEMENT DISORDERS, 2004, 19 : S2 - S2
  • [48] Targeting Alpha-Synuclein for the Treatment of Parkinson's Disease
    Rohn, Troy T.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (02) : 174 - 179
  • [49] The central role of alpha-synuclein in Parkinson's disease
    Halliday, G.
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 54 - 54
  • [50] Lymphomonocyte alpha-synuclein levels in aging and in Parkinson disease
    Brighina, Laura
    Prigione, Alessandro
    Begni, Barbara
    Galbussera, Alessio
    Andreoni, Simona
    Piolti, Roberto
    Ferrarese, Carlo
    NEUROBIOLOGY OF AGING, 2010, 31 (05) : 884 - 885